Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-03 11:51:50 - browse：4515

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： As JPM 2024 winds down, some health tech firms project optimism

WSS

Wegovy, Zepbound and weight loss drugs that preserve muscle

Doulas covered by Medicaid under New York's new plan

David Sabatini, ex

FDA's Woodcock to retire early next year

A daunting task: navigating dual Medicare, Medicaid eligibility

Astellas still sees hope in its gene therapy after four deaths

hotspot

Wikipedia

focus

Medical leaders decry Supreme Court decision on affirmative action

NYU radiologists take on the challenge of expensive MRI machines

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

DeSantis can now import cheaper drugs. But will Biden get credit?

Hollywood unions extend contract negotiations for actors

Astellas still sees hope in its gene therapy after four deaths

ChatGPT in medicine: STAT answers readers' burning questions

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Alkermes shareholders re

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

focus

New England Journal of Medicine addresses racist history, slavery

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Three issues to watch in global health in 2024

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Weight loss drug costs may need more research, senator suggests

Readout LOUD podcast: live from JPM 2024

hotspot

entertainment

hotspot

focus